HospitalNews

Wockhardt Hospitals, Mumbai Central introduces treatment for diabetic foot ulcer

With the use of GFC, wounds have healed rapidly as compared to conventional ways of treatment

Wockhardt Hospitals has launched Diabetic Foot Ulcer clinic (DFU) to reduce chances of foot amputation due to diabetes by using Growth Factor Concentrate Therapy (GFC). This is a path-breaking therapy where growth factors derived from the patient’s platelets are further purified and used as an acellular growth factor giving consistent quality and quantity.  

During the launch of DFU clinic, Dr Parag Rindani, CEO, Wockhardt Group of Hospitals (Maharashtra) said “This the first-of-its-kind multi- speciality therapeutic approach which is being used for diabetic foot ulcer, because it has been augmented by growth factor concentrate, and supported by all conventional therapies and superspecialists. As a group, this team has come together to be able to bring relief to patients suffering from DFU.”

Dr Behram Pardiwala, Director, Internal Medicine, Wockhardt Hospitals, Mumbai Central says, “India is the second-largest diabetic country in the world and diabetes as we all are aware is a silent killer. People with diabetes develop corn, callouses, rough skin which further develop into full-fledged ulcers. Such patients should immediately seek medical assistance to avoid deeper ulceration and gangrene. Our team of researchers have successfully used GFC on patients to prevent diabetic foot amputation. We have used this therapy on about 50 to 52 patients so far who had come to us with Stage 1 (Foot at Risk) and Stage 2 (Ulcerated Foot) and Stage 3 (Crippled foot) wound or ulcer. Using a multidisciplinary approach and GFC, we have got astounding results. This therapy helps to avoid amputation which is the worst form of trauma for any diabetic patient.”

During the launch of this clinic, Vijay Sharma, Director, Regenerative Medicine, Wockhardt Hospitals said, “Chronic wounds have an enormous impact on the quality of life and health of patients and their families but are often an underestimated malady. By stimulating the body’s repair mechanism, regenerative medicine offers the promise to regenerate chronic non-healing wounds using autologous growth factors derived from the patient’s blood cells. Growth factors are the type of molecules that not only stimulate cell growth as the name suggests but also affect several other aspects of cell structure and mechanism. The activation of platelets releases several growth factors, and our research has demonstrated successful results in healing ulcerative wounds.”

With the use of GFC, wounds have healed rapidly as compared to conventional ways of treatment, many times preventing the need for surgery. GFC is a high-quality patient care therapy that helps to prevent amputation amongst DFU patients in terms of harming a patient’s quality of life and the burden on the healthcare system.

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Back to top button
Close
Close